Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 italian emergency departments – Results from a survey conducted in Piedmont
Keywords:
haemophilia, emergency treatment, emergency doctors’ knowledge, emergency department careAbstract
Background: Haemophilia and von Willebrand disease are the bleeding disorders most frequently encountered in the emergency department (ED), that are often the first point of contact for patients. Evidence suggests that management in the ED is currently suboptimal, mainly because the physicians have few opportunities to deal with this kind of patients. Objectives: We carried out a survey to investigate the management of patients with haemophilia A in Emergency Departments (EDs), and to understand the training needs of the involved physicians. Methods: Overall, in Piedmont Region there are 32 EDs, and considering that our survey was conducted on 21 physicians working in 23 Emergency Departments (EDs), this number is representative of the Region’s reality. The interviews were conducted through face-to-face meetings, including general aspects regarding the clinical characteristics and the management of patients, and self-evaluation of knowledge and interest in receiving information about the disease. Results: In 2019, 131 patients with haemophilia A were admitted (108 adults, 23 paediatric). The best-known and most widely available and used treatments were plasma derivatives, followed by first- and second-generation recombinant FVIII. More recent recombinant and bypassing agents were less known. Half of the interviewees considered their knowledge of bleeding disorders in general and haemophilia in particular to be “basic”, and only one third defined it as “good”; however, 86% expressed great interest in receiving information about the topic. Conclusions: The survey confirms the needs related to the clinical management of rare inherited clotting disorders in EDs. The physicians involved are keen to overcome this lack of knowledge, and proper initiatives should be implemented.
References
Schwartz KR, Rubinstein M. Haemophilia And Von Willebrand Disease In Children: Emergency Department Evaluation And Management. Pediatr Emerg Med Pract 2015;12(9):1-20; quiz 20-1.
Istituto Superiore di Sanità - Registro Nazionale Coagulopatie Congenite. Rapporti ISTISAN 20/14. Rapporto 2019. 2021, iii, 53 p. Francesca Abbonizio, R Biffoni, Romano Arcieri, Associazione Italiana Centri Emofilia (AICE) e Adele Giampaolo.
CDC. Data & Statistics on Haemophilia https://www.cdc.gov/ncbddd/hemophilia/data.html#:~:text=In%20the%20United%20States%2C%20most,for%20those%20with%20severe%20hemophilia.
National Haemophilia Foundation. Bleeding Disorders. https://www.hemophilia.org/bleeding-disorders-a-z
Zimmerman B, Valentino LA. Haemophilia: in review. Pediatr Rev 2013; 34(7):289-94
Dunn AL. Management and prevention of recurrent hemarthrosis in patients with haemophilia. Curr Opin Hematol 2005;12(5):390-4
Page D. Comprehensive care for haemophilia and other inherited bleeding disorders. Transfus Apher Sci 2019;58(5):565-568.
Srivastava A, Santagostino E, Dougall A et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158.
Singleton T, Kruse-Jarres R, Leissinger C. Emergency department care for patients with haemophilia and von Willebrand disease. J Emerg Med. 2010; 39: 158-165
Zakieh A, Siddiqu AH. Emergency department utilization by haemophilia patients in United States 2017; 23(3): e188-e193
Tagliaferri A, Di Perna C, Biasoli C, et al. A Web Site to Improve Management of Patients with Inherited Bleeding Disorders in the Emergency Department: Results at 2 Years. Semin Thromb Hemost 2016;42(5):589-98.
Lee A. Emergency management of patients with bleeding disorders: Practical points for the emergency physician. Transfusion and Apheresis Science 2019; 58:553–562.
Philippe de Moerloose P, Davis JA, El Fegoun SB, Habis R and Klamroth R. Barriers and challenges for the fast treatment of bleeds in the non-haemophilia treatment centre hospital setting. Haemophilia. 2020;00:1–9.
Livesey K, Yealy DM, Li J, Moore CG, Ragni MV. Von Willebrand disease in the emergency department. Haemophilia 2016;22(2):263-267.
Tebo C, Gibson C, Mazer-Amirshahi M. Haemophilia and von Willebrand disease: a review of emergency department management. J Emerg Med 2020; 58:756-766
Minhas HL, Giangrande PL. Presentation of severe haemophilia—A role for accident and emergency doctors? Emerg Med J. 2001;18(4):246-9
Chambost H, Gaboulaud V, Coatmélec B. What factors influence the age at diagnosis of haemophilia? Results of the French haemophilia cohort. J Pediatr 2002; 141(4):548-552
Mantik FJ, Gunawan S, Wowiling S. Knowledge about haemophilia among teachers of patients with haemophilia in Indonesia. Pediatric Hematology Oncology Journal 2020; 5(3):126-129
Peyvandi F, Lillicrap D, Mahlangu J et al. Haemophilia gene therapy knowledge and perception: results of an international survey. Res Pract Thromb Haemost 2020;4:644-651
Alhajri H, Darwish M, Richhariya D and Almemari A. Approach to Patients with Bleeding Disorders in the Emergency Department. EC Emergency Medicine and Critical Care 3.1 2019;20-28.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Berardino Pollio, Irene Ricca, Cristina Dainese, Federica Valeri, Alessandra Valpreda, Claudia Linari, Alessandra Borchiellini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
